Catharina A. Hartman
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (8)
Harmonized phenotyping and diverse population-specific studies are crucial for advancing gene discovery in psychiatric genetics. We conducted a genome-wide association study (GWAS) of DSM-defined lifetime Major Depressive Disorder (MDD) in 64,941 participants (25.7% cases) from the Dutch BIObanks Netherlands Internet Collaboration (BIONIC) consortium. SNP-based heritability was estimated at 13.4%, exceeding recent global meta-analyses, with a high genetic correlation (r = 0.89) to the latest major depression GWAS by the Psychiatric Genetics Consortium (PGC-MD). We identified a novel genome-wide significant locus in PALMD (P = 3.26 × 10⁻⁸), that was confirmed by GWAS-by-subtraction. Polygenic scores (PGSs) based on BIONIC predicted MDD in UKBiobank, and PGSs from PGC-MD predicted into BIONIC, with within-family analyses indicating minimal confounding. Genetic causal inference revealed associations with over 30 phenotypes. Twin concordance for MDD increased with polygenic burden, reinforcing its genetic architecture. This study emphasizes the power of harmonized phenotyping and regional biobanks in uncovering the genetic architecture of MDD, highlighting the value of population-specific studies for improving risk prediction and advancing psychiatric genetics.
Year:
2025
Background Psychiatric and somatic problems are highly prevalent, often co-occur and share part of their genetic background. Low socio-economic status (SES) is a risk factor for both. We examined whether low SES amplifies the effects of genetic susceptibility on depression, anxiety, body mass index (BMI), waist-hip-ratio (WHR), smoking and alcohol use, investigating and aggregated outcomes. Methods Data came from the population-based Lifelines Cohort Study (n=50,761). Anxiety, depression, body mass index, waist-hip-ratio, smoking, and alcohol use were analyzed individually and collectively using confirmatory factor analysis to model shared variance among outcomes. Polygenic risk scores (PRSs) were calculated based on recent genome-wide association studies (GWASs) of specific conditions. We performed GWASs and derived PRS of aggregated outcomes using genomic structural equation modelling (SEM). A latent SES factor was generated by educational attainment, occupational status, and disposable household income. Interaction effects of SES indices with PRSs were estimated using linear mixed regression. Results Eight of ten PRSs-by-SES interactions were significant ( ps <0.05) for depression, anxiety, BMI, smoking, and aggregated outcome level, but not for WHR ( p =0.07) and alcohol use ( p =0.67). Lower SES amplified the effects of PRSs on depression, anxiety, BMI, and smoking. At the aggregated outcome level, interaction effects were mostly smaller than effects for individual outcomes. Conclusions Our study demonstrates polygenic risk-by-SES interaction effects on depression, anxiety, BMI, and smoking. However, the effects were attenuated for PRSs derived from genomic SEM and aggregated outcomes, indicating limited additional etiological insights from modelling genetic and phenotypic overlap.
Year:
2025
Background Polygenic risk scores (PRSs) have recently become popular in predicting genetic susceptibility to common complex diseases. However, as PRSs only capture part of the genetic risk, imperfect prediction of outcomes is expected. Family history may capture additional genetic effects as well as those of shared family environment. Within-family design have the advantage to control potential bias, such as gene-environmental correlation, assortative mating, and population stratification. Our aims are to investigate the relative influence of PRS and family history on general and abdominal obesity using between and within family approaches. Methods We included 50,747 participants of the Lifelines Cohort Study. Body mass index (BMI) and waist-hip-ratio (WHR) were calculated by measured height, weight, waist circumference (WC) and hip circumference. Family history was defined as the number of obese first-degree relatives. PRSs were calculated based on recent large genome-wide association studies for BMI, WC and WHR. The between-family PRS was defined as the mean sibling PRS, and the within-family PRS as the difference between the individual and mean PRS. Linear mixed regression models were used to estimate the effect of (between- and within-family) PRS and family history on BMI, WC and WHR. Structural equation modeling was used to estimate the relative effects of parental PRS (via offspring’s PRS) and parental phenotype on offspring’s phenotype. Results PRS and family history together explained 11.81%, 7.26% and 3.62% of the variance in BMI, WC and WHR, respectively, where family history explained additional variance on top of PRS. Among 2,003 parent-offspring trios, transmission of the PRSs from parents to offspring ( β =0.48-0.52) resulted in a significant effect of offspring’s PRSs on offspring’s BMI, WC and WHR ( β =0.14-0.16). In addition, parental BMI, WC and WHR, were strongly positively associated with offspring’s BMI, WC and WHR ( β =0.14-0.27), independent of the parent-offspring transmission. Between- and within-family PRS had similar effect sizes, while between-family PRS explained more variance than within-family PRS for obesity indices among siblings (1.91% vs 6.70% for BMI, 1.25% vs 4.10% for WC, and 0.72% vs 2.61% for WHR). Conclusions The combination of PRS and family history improved the prediction of indices for general and abdominal obesity. In addition to the genetic effects captured by the parent-offspring PRS transmission, parental BMI, WC and WHR also independently influenced offspring’s BMI, WC and WHR, reflecting additional genetic effects not captured by PRS as well as effects of the shared family environment. Similar effects of between- and within-family PRSs indicated little bias (e.g., gene-environmental correlations, assortative mating, and population stratification) in the genetic effects on indices of obesity.
Year:
2025
Social behaviour is a heritable, context-dependent trait that changes across social settings and development, influencing wellbeing and mental health. We present the first genome-wide meta-regression study of social behaviour from infancy to early adulthood, leveraging 491,246 repeat measures of low prosocial behaviour and peer/social difficulties in European-ancestry cohorts (N eff =121,777, N ind =73,321). We modelled heterogeneity in genetic effects across social domains, informants, and ages (2–29 years), capturing social context through genomic influences. Six loci were identified, including variation within CADM2 ( p =2.51x10 -9 ). The SNP-based heritability was modest (2–7%), and the genetic architecture of social behaviour multidimensional. Polygenic scores demonstrated predictability and accuracy in independent European-ancestry cohorts and, partially, in African-ancestry cohorts (N ind =16,305). Genetic correlations with later-life and mental health outcomes showed context-dependent patterns. Modelling predicted onsets of associations with social behaviour revealed distinct profiles, as observed for autism, ADHD, depression and schizophrenia, highlighting novel opportunities to genetically proxy developmental trajectories.
Year:
2025
Introductory paragraph Panic attacks, sudden episodes of intense fear accompanied by physical and psychological symptoms, affect approximately 23% of the population 1,2 . Panic disorder, diagnosed in 2– 4% 3 , involves recurrent attacks followed by persistent worry about further attacks, leading to functional impairment and avoidance behaviours 1,2 . We conducted genome-wide association meta-analyses of panic attacks and panic disorder (61,746 and 29,775 cases, respectively, and 105,814 controls), identifying the first genome-wide significant variants for both traits (16 for panic attacks; 7 for panic disorder). Geneset analysis using single-cell RNA sequencing data implicated afferent neurons from the eye, heart, and lung in panic attacks, suggesting a critical role for sensory processing and interoceptive awareness. Further analyses suggested that these associations generalize to other psychiatric disorders. These findings offer novel insights into the biological mechanisms underlying panic, the role of afferent neurons, and may inform the development of more targeted and effective interventions.
Year:
2025
Inflammation is associated with a range of neuropsychiatric symptoms; however, the nature of the causal relationship is unclear. We used complementary non-genetic, genetic risk score (GRS), and Mendelian randomization (MR) analyses to examine whether inflammatory markers are associated with affect, depressive and anxiety disorders, and cognition. We tested in ≈ 55,098 (59% female) individuals from the Dutch Lifelines cohort the concurrent/prospective associations of C-reactive protein (CRP) with: depressive and anxiety disorders; positive/negative affect; and attention, psychomotor speed, episodic memory, and executive functioning. Additionally, we examined the association between inflammatory GRSs (CRP, interleukin-6 [IL-6], IL-6 receptor [IL-6R and soluble IL-6R (sIL-6R)], glycoprotein acetyls [GlycA]) on these same outcomes (N max =57,946), followed by MR analysis examining evidence of causality of CRP on outcomes (N max =23,268). In non-genetic analyses, higher CRP was associated with a depressive disorder, lower positive/higher negative affect, and worse executive function, attention, and psychomotor speed after adjusting for potential confounders. In genetic analyses, CRP GRS was associated with any anxiety disorder (β = 0.002, p = 0.037) whereas GlycA GRS was associated with major depressive disorder (β = 0.001, p = 0.036). Both CRP GRS (β = 0.006, p = 0.035) and GlycA GRS (β = 0.006, p = 0.049) were associated with greater negative affect. Inflammatory GRSs were not associated with cognition, except sIL-6R GRS which was associated with poorer memory (β=-0.009, p = 0.018). There was weak evidence for a CRP-anxiety association using MR (β = 0.12; p = 0.054). Genetic and non-genetic analyses provide consistent evidence for an association between CRP and negative affect. These results suggest that dysregulated immune physiology may impact a broad range of trans-diagnostic affective symptoms.
Year:
2024
Objective A thorough and comprehensive knowledge base on the extent of comorbidity of attention‐deficit/hyperactivity disorder (ADHD) and somatic conditions is needed. Method We compared the prevalence of a wide range of somatic conditions in individuals with and without ADHD and described sex and lifecourse differences. Individuals with an ADHD diagnosis ( N = 87,394) and age and sex‐matched individuals without an ADHD diagnosis were identified from a large health claims dataset representative of the general German population, including both primary and specialized care ( N = 4.874,754). Results were provided for the full sample as well as stratified for sex and age (<12 years, 13–17 years, 18–29 years, 30–59 years, ≥60 years). Results The results showed that ADHD is associated with a wide variety of somatic conditions across the entire lifecourse. Specifically neurological disorders such as Parkison's disease (odds ratio [OR]: 5.21) and dementia (OR: 2.23), sleep‐related disorders (OR: 2.38) and autoimmune disorders affecting the musculoskeletal, digestive, and endocrine system (fibromyalgia OR: 3.33; lupus OR: 2.17) are strongly and significantly associated with ADHD. Additionally, ADHD is associated with higher occurrence of common acute diseases typically treated by the general practitioner, hinting at an overall general lower health status. Sex differences in somatic comorbidity were not prominent. Age differences, in contrast, stood out: in particular endocrine, cardiovascular, and neurological disorders had an early onset in individuals with compared to individuals without ADHD. Conclusion This research underlines the high burden of disease due to somatic conditions among individuals with ADHD. The findings indicate the need for preventive measures to reduce comorbidity.
Year:
2024
Introduction Attention deficit hyperactivity disorder (ADHD) is associated with risk‐taking behavior, leading to accidents and unintentional injuries (summarized here as incidents). Main aim of this study is to determine if men and women with and without ADHD differ in the risk of mild (treated outpatient) and severe (treated inpatient) incidents across the adult lifespan (age groups: 18–29; 30–59, and ≥60 years). Secondary aim: investigate the role of comorbid mental disorders and drugs for the treatment of these comorbidities, and ADHD‐medication. Methods Using anonymized German claims data ( N = 4,575,027), adults with ADHD diagnosis during 2016–2019 ( N = 17,041) were compared with a 1:4 age and sex‐matched group without ADHD diagnosis. Regression analyses statistically tested group differences. Results Incidents occur in a U‐shaped form across the adult lifespan. Individuals with ADHD show the same pattern but at a substantially increased risk of both mild and severe incidents throughout the lifespan. Women without ADHD are at lower risk in young adulthood than men but at higher risk in older adulthood. Women with ADHD show the same pattern for severe incidents, but for mild incidents they have the highest risk throughout the lifespan. Co‐occurring anxiety disorder and the use of psycholeptics and ADHD‐medication decreased the incident risk. Conclusion We extend available knowledge which has hitherto focused on young adult males and traffic accidents. ADHD is associated with increased incidents across the adult lifespan, with distinct patterns regarding age, sex, and incident severity. An accurate diagnosis of ADHD in adulthood provides the first step towards prevention of accidents and unintentional injuries.
Year:
2022
Collaborators (84)
Harold Snieder
Scientific Staff
University Medical Center Groningen
Tomas Paus
Group leader
BarcelonaBeta Brain Research Center
Melissa Wake
Professorial Fellow
University of Melbourne
Angelica Ronald
Professor of Psychology and Genetics
University of Surrey
Naomi Wray
University of Queensland
Eveline de Zeeuw
University of Amsterdam
Anni Malmberg
University of Helsinki
Robert Plomin
Research Professor in Behavioural Genetics
King’s College London
George Davey Smith
Academic , Professor of Clinical Epidemiology
University of Bristol
Ted Reichborn-Kjennerud
Professor
University of Oslo
Brenda WJH Penninx
Professor
-
Sang hyuck Lee
King’s College London
René Pool
University of Amsterdam
Gerome Breen
Professor of Psychiatric Genetics
King’s College London
Nathan Skene
Associate Professor and UK DRI Group Leader
Imperial College London
Alexander Neumann
Researcher
Erasmus University Rotterdam
Sanjeevan Jahagirdar
Max Planck Institute for Psycholinguistics
Andrew McIntosh
Professor of Biological Psychiatry
University of Edinburgh
Alexandra Havdahl
Prof
Norwegian Institute of Public Health
Rosa Bosch
divisió de salut mental althaia xarxa assistencial universitària de manresa manresa
Matthew Hotopf
South London and Maudsley NHS Foundation Trust
Leen 't Hart
AssociateProfessor
Leiden University Medical Center
Carol Wang
University of Western Australia
Kaili Rimfeld
Lecturer (Assistant Professor) in Psychology
Royal Holloway, University of London
Vincent W. V. Jaddoe
Erasmus MC
Cherie Armour
The Queen's University Belfast
Eero Vuoksimaa
University of Helsinki
Melissa H Black
Associate Professor
La Trobe University
Albertine J. Oldehinkel
Scientific Staff, Professor
University Medical Center Groningen
F. Huider
University of Amsterdam
Brittany Mitchell
Senior Research Fellow
QIMR Berghofer Medical Research Institute
Alan Murphy
Imperial College London
Jordi Sunyer Deu
Chair
Barcelona Institute for Global Health
Marta Ribases
-
Ilja Nolte
Senior Researcher of Statistical Genetics and Genetic Epidemiology
University Medical Center Groningen
Thomas Bourgeron
Université Paris Diderot
Evangelos Vassos
Clinical Reader
King’s College London
Henning Tiemeier
Professor of Maternal and Child Health
Harvard T.H. Chan School of Public Health
Jan Buitelaar
Professor, Principal Investigator
Radboud University Medical Center
James Walters
Director and Clinical Professor
Cardiff University
Sarah Medland
QIMR Berghofer Medical Research Institute
Donald M. Lyall
-
David Whiteman
Deputy Director
QIMR Berghofer Medical Research Institute
Nathalie Kingston
Research Professor
University of Cambridge
Nora Fernandez-Jimenez
Assistant Professor in Genetics
University of the Basque Country
Angela Morgan
University of Melbourne
Enda Byrne
Senior Research Fellow
University of Queensland
Tanja G M Vrijkotte
University of Amsterdam
Michela Noseda
Imperial College London
Eco de Geus
University of Amsterdam
Geneviève Morneau-Vaillancourt
Professeure adjointe
Université de Sherbrooke
Jose Ramon Bilbao
Full Professor
University of the Basque Country
Nicholas Martin
Senior Scientist and Senior Principal Research Fellow
QIMR Berghofer Medical Research Institute
Josep Antoni Ramos-Quiroga
Head of the Deparment of Psychiatry
Hospital Universitari Vall d'Hebron
Mariona Bustamante
Staff scientist
Barcelona Institute for Global Health
Jari Lahti
Professor
University of Helsinki
Christel Middeldorp
Professor
-
Alina Rodriguez
professor
University of Lincoln
Tarunveer Singh Ahluwalia
Associate Professor
University of Copenhagen
Sheena Reilly
Griffith University
Daniel J Smith
Chair of Psychiatry
University of Edinburgh
Marjo-Riitta Jarvelin
Professor
University of Oulu
Elham Assary
King’s College London
Edith J. M. Feskens
Professor, Dean of Research
Wageningen University & Research
Henrik Larsson
Professor
Karolinska Institutet
paul lichtenstein
Head of Department
Karolinska Institutet
Andrew Whitehouse
University of Western Australia
Ebba Du Rietz
Assistant Professor
Karolinska Institutet
Charlotte Cecil
Associate Professor Biological Psychopathology
Erasmus MC
Ian B. Hickie
Co-Director Health and Policy
University of Sydney
Catherine Olsen
QIMR Berghofer Medical Research Institute
Dan Stein
Professor and Chair of Psychiatry
University of Cape Town
Christine Ecker
Heisenberg Professor
Goethe University Frankfurt
Bernardo de Azevedo Pinto Castro Maciel
Vrije Universiteit Amsterdam
Eivind Ystrom
Professor of personality psychology
University of Oslo
Sven Bölte
Professor, head of the Pediatric Neuropsychiatry Unit
Healthcare Provision, Stockholm County
Jonathan Coleman
Senior Lecturer in Statistical Genetics
King’s College London
Craig Pennell
Professor and Chair Obstetrics and Gynaecology, Professor Maternal Fetal Medicine
Newcastle University
Teemu Palviainen
University of Helsinki
Jaakko Kaprio
Research Director
University of Helsinki
Thalia Eley
Professor of Developmental Behavioural Genetics
King’s College London
Ellen Verhoef
Max Planck Institute for Psycholinguistics
Saakshi Kakar
King's College London
Dorret I Boomsma
Full professor
University of Amsterdam
Make your next move.
Prepare your application
Review drafts before you send them.